Loading...
glycosphingolipid
The anti-extended Type I glycosphingolipid antibodies are used in the treatment or prevention of diseases or disorders in mammals, including humans, resulting from improper activity or metabolism of same; resulting, causing or associated with; or the presence thereof, for example, in a cancer, such as colorectal cancer, or other pathology.
-
- Derivation: Human
- Type: scFv
- Application: ELISA, WB, Neut, FuncS
-
- Derivation: Human
- Type: Fab
- Application: ELISA, IF, FuncS
-
- Derivation: Human
- Type: IgG
- Application: WB, RIA, FuncS
- Recombinant Anti-glycosphingolipid Antibody scFv Fragment (MOB-403-S(P))
-
- Derivation: Mouse
- Type: scFv
- Application: WB, IP, FuncS
- Recombinant Anti-glycosphingolipid Antibody Fab Fragment (MOB-403-F(E))
-
- Derivation: Mouse
- Type: Fab
- Application: RIA, WB, FuncS
-
- Derivation: Mouse
- Type: IgG
- Application: ELISA, IP, FuncS
- Human Anti-Glycosphingolipid Antibody, mRNA (TAB-318CL-mRNA)
-
- Species Reactivity: Human
-
- Species Reactivity: Human
- Type: ADCC enhanced antibody
-
- Species Reactivity: Human
- Type: Antibody
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.